Glucagonlike Peptide 1-Based Therapies Associated With Acute Pancreatitis in Study

In a study by Sonal Singh, M.D., M.P.H., of The Johns Hopkins
University School of Medicine, Baltimore, and colleagues, treatment
with the glucagonlike peptide-1 (GLP-1)-based therapies sitagliptin
and exenatide were associated with increased odds...

Source: Drugs.com - Clinical Trials - February 26, 2013 Category: Pharmaceuticals Source Type: clinical trials